en.wikipedia.org/wiki/Abdullahi_v._Pfizer,_Inc.

The Kano trovafloxacin trial litigation arose out of a clinical trial conducted by the .... ever been treated with Trovan, and then only after all other antibiotics failed.

harvardlawreview.org/2010/01/second-circuit-looks-beyond-complaint-to-find-state-action-requirement-satisfied-ae-abdullahi-v-pfizer-inc-562-f-3d-163-2d-cir-2009

18 hours ago ... Second Circuit Looks Beyond Complaint To Find State Action Requirement Satisfied.

www.quimbee.com/cases/abdullahi-v-pfizer-inc

Pfizer, Inc., including the facts, issue, rule of law, holding and reasoning, key ... and the University of Illinois—even subscribe directly to Quimbee for all their law  ...

www.courtlistener.com/opinion/2182818/pfizer-inc-v-teva-pharmaceuticals-usa-inc

Aug 12, 2011 ... PFIZER INC., Pfizer Ltd., and Pfizer Ireland Pharmaceuticals ...... Jacob Rajfer, et al., Nitric Oxide as a Mediator of Relaxation of the .... Procter & Gamble, 566 F.3d 989 (internal quotation marks omitted) (quoting In re O'Farrell, ...

www.chamberlitigation.com/sites/default/files/cases/files/18181818/Petition%20for%20Permission%20to%20Appeal%20--%20Adamyan%20v.%20Pfizer%2C%20Inc.%20%28Ninth%20Circuit%29.pdf

ALIDA ADAMYAN, et al.,*. Plaintiffs-Respondents, v. PFIZER INC.,. Defendant- Petitioner. Petition for Permission to Appeal From United States District Court,.

www.plainsite.org/dockets/lalwlh4a/new-york-southern-district-court/coultrip-et-al-v-pfizer-inc

Coultrip et al v. Pfizer, Inc ... Christopher Farrell, Plaintiff ...... NOTICE OF APPEARANCE by Holly Rich on behalf of Pfizer, Inc (Rich, Holly) (Entered: 09/27 /2011).

www.ded.uscourts.gov/sites/default/files/opinions/gms/2012/july/09-307.pdf

Jul 24, 2012 ... In this consolidated patent infringement action, plaintiffs Pfizer Inc., Warner- Lambert ..... v. RE '920 Patent, Claim 2. 49. Claim 2 of the RE '920 Patent reads: "[ a] method for ..... 2006) (quoting In re O'Farrell, 853 F.2d 894,903-04 (Fed. ...... 37 Andruszkiewicz, R. et al., Chemoenzymatic Synthesis of (R)- And ...

ascopubs.org/doi/abs/10.1200/jco.2009.27.15_suppl.5042

Dec 12, 2016 ... ... overall survival (OS) with sunitinib compared to IFN-α was: 26.4 vs. ... Pfizer, Inc. Bayer, GlaxoSmithKline, Novartis, Pfizer, Roche, Wyeth ...

ascopubs.org/doi/abs/10.1200/JCO.2019.37.7_suppl.TPS337

Feb 26, 2019 ... C1: pts with mCRPC (all comers) (N = 560); C2: pts with DDR gene mutations ... and DDR mutation status (deficient vs. nondeficient/unknown). ... This study was sponsored by Pfizer Inc. Clinical trial information: ... Ferrell et al.